Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Rheumatology 2, 5–6 (1 January 2006) | doi:10.1038/ncprheum0056
Tumor necrosis factor antagonists do not increase cancer risk in patients with RA
Abstract
Askling J et al. (2005) Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumor necrosis factor antagonists. Ann Rheum Dis 64: 1414–1420 Askling J et al. (2005) Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumor necrosis factor antagonists.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
